The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: A dual microdialysis probe analysis

European Journal of Neuroscience

Volumn 18, Issue 4, 2003, Pages 856-868

  Bianchi, L ^a   Galeffi, F ^a   Bolam, J P ^b   Della Corte, L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MRC Anat Neuropharmacology Unit   (United Kingdom)

Author keywords

AMPA; Aspartate; GABA; Globus pallidus; Glutamate; Kainic acid; Neostriatum; Striatonigral; Striatopallidal; Striatum; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; ASPARTIC ACID; GLUTAMIC ACID; KAINIC ACID; OXIDOPAMINE;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; GLOBUS PALLIDUS; MALE; MICROANALYSIS; MICRODIALYSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ADRENERGIC AGENTS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ASPARTIC ACID; BASAL GANGLIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXCITATORY AMINO ACID AGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; KAINIC ACID; MALE; MICRODIALYSIS; MODELS, ANIMAL; OXIDOPAMINE; PARKINSON DISEASE; POTASSIUM; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE;

EID: 0041317103     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02795.x     Document Type: Article

References (65)

1. Abarca, J. & Bustos, G. (1999) Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway. Neurochem. Int., 35, 19-33.
2. Albin, R.L., Young, A.B. & Penney, J.B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci., 12, 366-375.
3. Alexander, G.E. & Crutcher, M.E. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci., 13, 266-271.
4. Alexander, G.E., Crutcher, M.D. & DeLong, M.R. (1990) Basal gangliathalamocortical circuits - parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. In Uylings, H.B.M., Vaneden, C.G., Debruin, J.P.C., Corner, M.A. & Feenstra, M.G.P. (eds), Prefrontal Cortex. Its Structure, Function and Pathology. Prog. Brain Res., 85, Elsevier Science Publishers, Amsterdam, pp 119-146.
5. Aziz, T., Peggs, D., Sambrook, M.A. & Crossman, A.R. (1991) Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) -induced parkinsonism in the primate. Movement Disord., 6, 288-292.
6. Baik, J.-H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M. & Borrelli, E. (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature, 377, 424-428.
7. Bergman, H., Feingold, A., Nini, A., Raz, A., Slovin, H., Abeles, M. & Vaadia, E. (1998) Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci., 21, 32-38.
8. Bergman, H., Wichmann, T. & DeLong, M. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science, 249, 1436-1438.
9. Bernard, V., Gardiol, A., Faucheux, B., Bloch, B., Agid, Y. & Hirsch, E.C. (1996) Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion. J. Comp. Neurol., 368, 553-568.
10. Bernath, S. (1991) Calcium-independent release of amino acid neurotransmitters: fact or artifact? Prog. Neurobiol., 34, 57-91.
11. Betarbet, R., Porter, R.H.P. & Greenamyre, J.T. (2000) GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation. J. Neurochem., 74, 1166-1174.
12. Bevan, M.D., Magill, P.J., Terman, D., Bolam, J.P. & Wilson, C.J. (2002) Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci., 25, 525-531.
13. Bianchi, L., Colivicchi, M.A., Bolam, J.P. & Della Corte, L. (1998) The release of amino acids from rat neostriatum and substantia nigra in vivo: a dual microdialysis probe analysis. Neuroscience, 87, 171-180.
14. Bianchi, L., Della Corte, L. & Tipton, K.F. (1999) Simultaneous determination of basal and evoked output levels of aspartate, glutamate, taurine and γ-aminobutyric acid during microdialysis and from superfused brain slices. J. Chromatogr. B, 723, 47-59.
15. Bianchi, L., Sharp, T., Bolam, J.P. & Della Corte, L. (1994) The effect of kainic acid on the release of GABA in rat neostriatum and substantia nigra. Neuroreport, 5, 1233-1236.
16. Biggs, C.S., Fowler, L.J., Whitton, P.S. & Starr, M.S. (1997) Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal D2 receptors via the indirect striatal output pathway? Brain Res., 753, 163-175.
17. Biggs, C.S. & Starr, M.S. (1997) Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra. Neurosci. Biobehav. Rev., 21, 497-504.
18. Campbell, K., Kalen, P., Wictorin, K., Lundberg, C., Mandel, R.J. & Bjorklund, A. (1993) Characterization of GABA release from intrastriatal striatal transplants: dependence on host-derived afferents. Neuroscience, 53, 403-415.
19. Chevalier, G. & Deniau, J.M. (1990) Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci., 13, 277-280.
20. Crossman, A.R. (1989) Neural mechanisms in disorders of movement. Comp. Biochem. Physiol., 93A, 141-149.
21. Crossman, A.R. (1990) A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Movement Disord., 5, 100-108.
22. DeLong, M.R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci., 13, 281-285.
23. Di Chiara, G. (1990) In vivo brain dialysis of neurotransmitters. Trends Pharmacol., 11, 116-121.
24. Difazio, M.C., Hollingsworth, Z., Young, A.B. & Penney, J.B. (1992) Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology, 42, 402-406.
25. Dunah, A.W. & Standaert, D.G. (2001) Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J. Neurosci., 21, 5546-5558.
26. Dunah, A.W., Wang, Y., Yasuda, R.P., Kameyama, K., Huganir, R.L., Wolfe, B.B. & Standaert, D.G. (2000) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol., 57, 342-352.
27. 3H]amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding to rat striatal membranes: effects of selective brain lesions. J. Neurochem., 51, 579-586.
28. Fattori, M., Bianchi, L., Colivicchi, M.A., Chechi, M., Bolam, J.P. & Della Corte, L. (2001) The evoked release of GABA and taurine from the striatopallidal (indirect) pathway: a dual probe microdialysis study in the freely-moving rat. Br. J. Pharmacol., 133, 173P.
29. Ferraro, L., Antonelli, T., O'Connor, W.T., Fuxe, K., Soubrie, P. & Tanganelli, S. (1998) The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: Functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. J. Neurosci., 18, 6977-6989.
30. Galeffi, F., Bianchi, L., Zamfirova, R., Nerini, M., Bolam, J.P. & Della Corte, L. (1997) The effect of 6-hydroxydopamine lesions on the evoked release of endogenous GABA and taurine in the direct and indirect pathways of the basal ganglia of the rat in vivo. Soc. Neurosci. Abstr., 23, 746.
31. Ganguly, A. & Keefe, K.A. (2001) Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons. Neuroscience, 103, 405-412.
32. Gerfen, C.R. (2000) Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci., 23 (Suppl.): Basal ganglia, Parkinson's disease and levodopa therapy), S64-S70.
33. Gerfen, C.R., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma, F.J. & Sibley, D.R. (1990) D1 and D2 dopamme receptor regulated gene expression of striatonigral and striatopallidal neurons. Science, 250, 1429-1432.
34. Gerfen, C.R. & Wilson, C.J. (1996) The Basal Ganglia. In Björklund, A., Hökfelt, T. & Swanson, L. (eds), Integrated Systems of the CNS, Part III. Handbook of Chemical Neuroanatomy 12. Elsevier Science, Amsterdam, pp 369-466.
35. Hayes, J., Tipton, K.F., Bianchi, L. & Della Corte, L. (2001) Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine. Brain Res. Bull., 55, 239-245.
36. Hirsch, E.C., Perier, C., Orieux, G., Francois, C., Feger, J., Yelnik, J., Vila, M., Levy, R., Tolosa, E.S., Marin, C., Herrero, M.T., Obeso, J.A. & Agid, Y. (2000) Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci., 23 (Suppl.): Basal ganglia, Parkinson's disease and levodopa therapy), S78-S85.
37. Hudson, J.L., van Horne, C.G., Strömberg, I., Brock, S., Clayton, J., Masserano, J., Hoffer, B.J. & Gerhardt, G.A. (1993) Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res., 626, 167-174.
38. Kawaguchi, Y., Wilson, C.J & Emson, P.C (1990) Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci., 10, 3421-3438.
39. Lindefors, N., Brodin, E., Tossman, U., Segovia, J. & Ungerstedt, U. (1989) Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Exp. Brain Res., 74, 527-535.
40. MacLeod, N.K., Ryman, A. & Arbuthnott, G.W. (1990) Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat. Neuroscience, 38, 447-456.
41. Marti, M., Sbrenna, S., Fuxe, K., Bianchi, C., Beani, L. & Morari, M. (1999) In vivo changes of striatal NMDA receptor mediated regulation of striatal and nigral glutamate release during Parkinson's disease. In Rollema, H., Abercrombie, E., Sulzer, D. & Zackheim, J. (eds), Monitoring molecules in Proceedings of the 8th International Conference on in vivo neuroscience. Methods. Newark the State University of New Jersey, 179-180.
42. Marti, M., Sbrenna, S., Fuxe, K., Bianchi, C., Beani, L. & Morari, M. (2000) Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats. Eur. J. Neurosci., 12, 1848-1850.
43. Meshul, C.K., Emre, N., Nakamura, C.M., Allen, C., Donohue, M.K. & Buckman, J.F. (1999) Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience, 88, 1-16.
44. Mink, J.W. (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog: Neurobiol., 50, 381-425.
45. Morari, R., O'Connor, W.T., Ungerstedt, U., Bianchi, C. & Fuxe, K. (1996) Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat-II. Evidence for striatal N-methyl-d-aspartate receptor regulation of striatonigral GABAergic transmission and motor function. Neuroscience, 72, 89-97.
46. Obeso, J.A., RodriguezOroz, M.C., Rodriguez, M., Lanciego, J.L., Artieda, J., Gonzalo, N. & Olanow, C.W. (2000) Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci., 23 (Suppl.): Basal ganglia, Parkinson's disease and levodopa therapy), S8-S19.
47. Ochi, M., Koga, K., Kurokawa, M., Kase, H., Nakamura, J. & Kuwana, Y. (2000) Systemic administration of adenosine A (2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study. Neuroscience, 100, 53-62.
48. Patel, D.R., Young, A.M.J. & Croucher, M.J. (2001) Presynaptic [alpha]-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study. Neuroscience, 102, 101-111.
49. Paxinos, G. & Watson, C. (1986) The Rat Brain in Sterotaxic Coordinates. Academic Press, Sydney.
50. Paxinos, G. & Watzon C. (1997) The Rat Brain in Stereotaxic Coordinates. Compact third edition, Academic Press, San Diego.
51. Porter, R.H.P., Greene, J.G., Higgins, D.S. & Greenamyre, J.T. (1994) Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci., 14, 7192-7199.
52. Reid, M.S., Herrera-Marschitz, M., Kehr, J. & Ungerstedt, U. (1990) Striatal dopamine and glutamate release: effects of intranigral injections of substance P. Acta. Physiol. Scand., 140, 527-537.
53. Robertson, R.G., Graham, W.C., Sambrook, M.A. & Crossman, A.R. (1991) Further investigation into the pathophysiology of MPTP-induced parkinsonism in the primate - an intracerebral microdialysis study of γ-aminobutyric acid in the lateral segment of the globus pallidus. Brain Res., 563, 278-280.
54. Samuel, D., Errami, M. & Nieoullon, A. (1990) Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl) propyl-1-phosphonic acid binding. J. Neurochem., 54, 1926-1933.
55. Sarre, S., Jonkers, N., Izurieta-Sanchez, S.P., Torfs, D., Ebinger, G. & Michotte, Y. (2001) In vivo microdialysis studies of the substantia nigra after a 6-hydroxydopamine lesion. In O'Connor, W.T., Lowry, J.P., O'Connor, J.J. & O'Neill, R.D. (eds), Monitoring molecules in neuroscience. Proceedings of the 9th International Conference on in vivo Methods. University College Dublin, Dublin, 257-258.
56. Segovia, J., Tossman, U., Herrera-Marschitz, M., Garcia-Munoz, M. & Ungerstedt, U. (1986) γ-aminobutyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat. Neurosci. Lett., 70, 364-368.
57. Smith, Y., Bevan, M.D., Shink, E. & Bolam, J.P. (1998) Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience, 86, 353-387.
58. Snyder, G.L., Allen, P.B., Fienberg, A.A., Valle, C.G., Huganir, R.L., Nairn, A.C. & Greengard, P. (2000) Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci., 20, 4480-4488.
59. Tossman, U., Segovia, J. & Ungerstedt, U. (1986) Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis. Acta. Physiol. Scand., 127, 547-551.
60. Tremblay, M., Salin, P. & Soghomonian, J.J. (1995) Effect of 6-OHDA lesions on striatal mRNA levels encoding for glutamate receptor subunits. Neuroreport, 6, 2225-2229.
61. Ulas, J., Weihmuller, F.B., Brunner, L.C., Joyce, J.N., Marshall, J.F. & Colman, C.W. (1994) Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J. Neurosci., 14, 6317-6324.
62. Wichmann, T. & DeLong, M.R. (1996) Functional and pathophysiological models of the basal ganglia. Curr. Opinion Neurobiol., 6, 751-758.
63. Wu, Y., Richard, S. & Parent, A. (2000) The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res, 38, 49-62.
64. Wullner, U., Testa, C.M., Catania, M.V., Young, A.B. & Penney, J.B. (1994) Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res., 645, 98-102.
65. +-depolarization, lesions and peptidase inhibition. Neuroscience, 63, 415-425.